Targeted therapies are used in patients with a set gene expression pattern. A targeted therapy that prevents the activation of the estrogen receptor in breast cancer would be beneficial to which type of patient? a. patients who express the EGFR receptor in normal cells b. patients with a mutation that inactivates the estrogen receptor c. patients with lots of the estrogen receptor expressed in their tumor d. patients that have no estrogen receptor expressed in their tumor
Added by Christopher G.
Step 1
This is because the therapy would block the activation of the receptor, potentially slowing down or stopping the growth of the cancer cells that rely on estrogen signaling. Show more…
Show all steps
Your feedback will help us improve your experience
Sri K and 55 other Biology educators are ready to help you.
Ask a new question
Labs
Want to see this concept in action?
Explore this concept interactively to see how it behaves as you change inputs.
Key Concepts
Recommended Videos
The chemotherapy agent, Tamoxifen, is effective at blocking the ability of estrogen to stimulate cell division. Where does Tamoxifen bind to influence this response? Group of answer choices A.to the estrogen receptor B.to estrogen response elements C.to the promoter region of estrogen responsive genes D.to estrogen activator proteins
Snida M.
Sri K.
Recommended Textbooks
Biology for AP Courses
Objective Biology for NEET
Introduction to General, Organic and Biochemistry
Transcript
Watch the video solution with this free unlock.
EMAIL
PASSWORD